Research demonstrates enhanced tumor reactive oxygen species production using bacterial outer membrane vesicles, suggesting a novel approach in cancer therapy.
Bacterial outer membrane vesicles (OMVs) possess inherent tumor-accumulation capabilities, immunostimulatory potential, and a size-dependent enhanced permeability and retention (EPR) effect, making them promising carriers for cancer immunotherapy. In this study,...
No takes yet. Share an insight, caveat, or question.
Dai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: